Synthesis, charecterization, and biological activities of some new pyrazoline derivatives, derived from Ethyl-2-(2, 5-dichloroanilido) acetohydrazide

International Journal of ChemTech Research

Volumn 2, Issue 3, 2010, Pages 1413-1425

  Sharma, Raj Narayan ^a   Sharma, K P ^b   Dixit, S N ^b  

^a NRI College of Engineering and Management   (India)

^b SMS Govt Model Science College   (India)

Author keywords

5 phenyl Pyrazoline; And Biological Activities; Characterization; Synthesis

Indexed keywords

1 (2,5 DICHLOROANILINOMALONYL) 3 (N 2' CYANOETHYL N 2,5 DICHLOROANILINO) 5 PHENYL PYRAZOLINE; 1 [(2 BROMO) 2,5 DICHLOROANILINOMALONYL)] 3 (N 2' CYANOETHYL N 2,5 DICHLOROANILINO) 5 PHENYL PYRAZOLINE; 1 [(2 CHLORO) 2,5 DICHLOROANILINOMALONYL)] 3 (N 2' CYANOETHYL N 2,5 DICHLOROANILINO) 5 PHENYL PYRAZOLINE; 1 [(2 ETHOXY) 2,5 DICHLOROANILINOMALONYL)] 3 (N 2' CYANOETHYL N 2,5 DICHLOROANILINO) 5 PHENYL PYRAZOLINE; 1 [(2 METHOXY) 2,5 DICHLOROANILINOMALONYL)] 3 (N 2' CYANOETHYL N 2,5 DICHLOROANILINO) 5 PHENYL PYRAZOLINE; 1 [(2 METHYL) 2,5 DICHLOROANILINOMALONYL)] 3 (N 2' CYANOETHYL N 2,5 DICHLOROANILINO) 5 PHENYL PYRAZOLINE; 1 [(2,5 DICHLOROANILINOMALONYL)] 3 (N 2' CYANOETHYL N 2,5 DICHLOROANILINO) 5 PHENYL PYRAZOLINE; 1 [(3 BROMO) 2,5 DICHLOROANILINOMALONYL)] 3 (N 2' CYANOETHYL N 2,5 DICHLOROANILINO) 5 PHENYL PYRAZOLINE; 1 [(3 CHLORO) 2,5 DICHLOROANILINOMALONYL)] 3 (N 2' CYANOETHYL N 2,5 DICHLOROANILINO) 5 PHENYL PYRAZOLINE; 1 [(3 ETHOXY) 2,5 DICHLOROANILINOMALONYL)] 3 (N 2' CYANOETHYL N 2,5 DICHLOROANILINO) 5 PHENYL PYRAZOLINE; 1 [(3 METHOXY) 2,5 DICHLOROANILINOMALONYL)] 3 (N 2' CYANOETHYL N 2,5 DICHLOROANILINO) 5 PHENYL PYRAZOLINE; 1 [(3 METHYL) 2,5 DICHLOROANILINOMALONYL)] 3 (N 2' CYANOETHYL N 2,5 DICHLOROANILINO) 5 PHENYL PYRAZOLINE; 1 [(4 BROMO) 2,5 DICHLOROANILINOMALONYL)] 3 (N 2' CYANOETHYL N 2,5 DICHLOROANILINO) 5 PHENYL PYRAZOLINE; 1 [(4 CHLORO) 2,5 DICHLOROANILINOMALONYL)] 3 (N 2' CYANOETHYL N 2,5 DICHLOROANILINO) 5 PHENYL PYRAZOLINE; 1 [(4 ETHOXY) 2,5 DICHLOROANILINOMALONYL)] 3 (N 2' CYANOETHYL N 2,5 DICHLOROANILINO) 5 PHENYL PYRAZOLINE; 1 [(4 FLORO) 2,5 DICHLOROANILINOMALONYL)] 3 (N 2' CYANOETHYL N 2,5 DICHLOROANILINO) 5 PHENYL PYRAZOLINE; 1 [(4 METHOXY) 2,5 DICHLOROANILINOMALONYL)] 3 (N 2' CYANOETHYL N 2,5 DICHLOROANILINO) 5 PHENYL PYRAZOLINE; 1 [(4 METHYL) 2,5 DICHLOROANILINOMALONYL)] 3 (N 2' CYANOETHYL N 2,5 DICHLOROANILINO) 5 PHENYL PYRAZOLINE; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; CINNAMOYL CHLORIDE; ETHYL 2 (2, 5 DICHLOROANILIDO) ETHANOATE; ETHYL 2 (2,5 DICHLOROANILIDO)ETHANOATE; N CINNAMOYL N 2' CYANOETHYL 2,5 DICHLOROANILINE; PYRAZOLINE DERIVATIVE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ALTERNARIA ALTERNATA; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS NIGER; BACTERIAL GROWTH; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG SYNTHESIS; ESCHERICHIA COLI; GROWTH INHIBITION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OBSERVATION; PSEUDOMONAS; STAPHYLOCOCCUS ALBUS; STAPHYLOCOCCUS AUREUS;

EID: 77957367740     PISSN: None     EISSN: 09744290     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Korgaokar, S. S.; Patil, P. H.; Shah, M. J; Parekh, H. H. Indian J. Pharm. Sci. 58, 222-225 (1996).
2. J. C. Jung, E. B. Watkins and M. A. Avery, Heterocycles 65, 77-94, (2005).
3. E. Palaska, M. Aytemir, T. Uzbay and D. Erol, Eur. J. Med. Chem. 36, 539-543, (2001).
4. Julian, L. Med. Hypotheses 69, 684-689, (2007).
5. Rajendra, P. Y.; Lakshmana, R. A.; Prasoona, L.; Murali, K.; Ravi, K. P. Bioorg. Med. Chem. Lett. 15, 5030-5034, (2005).
6. Ruhogluo, O.; Ozdemir, Z.; Calis, U.; Gumusel, B.; Bilgin, AA. Arzneimittelforschung 55, 431-436, (2005).
7. Ozdemir, Z.; Kandilici, HB; Gumusel, B.; Calis, U.; Bilgin, AA. Eur. J. Med. Chem. 42, 373-379, (2007).
8. Ashok Kumar, Sharma S, Bajaj K, Bansal D, Sharma S, Saxena KK, Lata S, Gupta B and Srivastava VK, Ind. J. Chem., 44B, 1979-1984, (2003).
9. Udupi, R. H., Narayanrao, S. and Bhat, A. R. Indian J. Heterocyclic Chemistry, 7, 217-220, (1998).
10. Amir M, Kumar S. Indian J. Chem 44B: 2532-2537, (2005).
11. Udupi, R. H.; Kushnoor, A.S.; Bhat, A. R. Indian J. Heterocycl. Chem. 8, 63-66, (1998).
12. Amir, M., Kumar, H., Khan, S. A. Bioorg. Med. Chem. Lett. 18, 918-922, (2008).
13. unawar A. Munawar, Muhammad Azad, Makshoof Athar and Paul W. Groundwater; Chemical Papers, Vol. 62, 3, 288-293, (2008).
14. Sadaf Sadiq Khan and Aurangzeb Hasan; Heterocycl. Commun. 13, 131-138, (2007).
15. Islam MR, Muhsin M. Bangladesh J. Pharmacol. 2, 7-12, (2007).
16. Hull, M.A.; Ko, S.C.W.; Hawcroft, G. Mol. Canc. Ther. 3, 1031-1039, (2004).
17. T. S. Jeong, K. S. Kim, J. R. Kim, K. H. Cho, S. Lee and W. S. Lee, Bioorg. Med. Chem. Lett. 14, 2719-2723, (2004), DOI: 10.1016/j.bmcl.2004.03.072.
18. T. Saibara, K. Toda, A. Wakatsuki, Y. Ogawa, M. Ono and S. Onishi, Toxicol. Lett. 143, 51-54, (2003). DOI: 10.1016/S0378-4274(03)00113-9.
19. El-Zohry MF, Younes MI, Metwally SA. Synthesis 972, (1984).
20. R. Lin, G. Chiu, Y. Yu, P. J. Connolly, S. Li, Y. Lu, M. Adams, A. R. Fuentes-Pesquera, S. L. Emanuel and L. M. Greenberger, Bioorg. Med. Chem. Lett. 17, 4557-4561; (2007) DOI: 10.1016/j. bmcl.2007.05.092.
21. S. Rollas, N. Gulerman and H. Erdeniz, Farmaco 57, 171-174, (2002).
22. Olsen, D. B., A. B. Eldrup, L. Bartholomew, B. Bhat, M. R. Bosserman, A. Ceccacci, L. F. Colwell, J. F. Fay, O. A. Flores, K. L. Getty, J. A. Grobler, R. L. LaFemina, E. J. Markel, G. Migliaccio, M. Prhavc, M. W. Stahlhut, J. E. Tomassini, M. MacCoss, D. J. Hazuda and S. S. Carroll. Antimicrob. Agents Chemother. 48: 3944-3953, (2004).
23. Abid M, Azam A. Bioorg Med Chem Lett 16, 2812-6, (2006).
24. Asha Budakoti, Abdul Roouf Bhat; Amir Azam; Eur. J. Med. Chem. Vol. 44, Issue- 3, 1317-1325, (2009).
25. Inoue Y, Kobayashi T, Masu A, Asahina K. Jpn Kokai Tokkyo Koho. 1991; JP03197467 [Chem Abstr. 115, 280054p, (1991).
26. A.A. Bekhit, H.M.A. Ashour, A.A. Guemei, Arch. Pharm. 338, 167, (2005).
27. M. Bagheri, M. Shekarchi, M. Jorjani, M.H. Ghahremani, M. A. Shafiee, Arch. Pharm. 337, 25, (2004).
28. J. H. Ahn, H. M. Kim, S. H. Jung, S. K. Kang, K. R. Kim, S. D. Rhee, S. D. Yong, H. G. Cheon and S. S. Kim, Bioorg. Med. Chem. Lett. 14, 4461-4465, (2004).
29. Joel O, Jean-Yves P, Patricia M, Pascal C, Fretier P, Philippe J, Dereuddre-Bosquet N, Dominique D, and Jean-Louis I, J. Med. Chem. 42, 4733-4740, (1999).
30. Maria L, Barreca, Jan B, Alba C, Erik DC, Laura DL, Hans DH, Monforte AM, Monfort P, Christophe P, RaoA and Maria Z, Design, J. Med. Chem 45, 5410-5413, (2002).
31. S. D. Bhardwaj, V. S. Jolly, Orient. J. Chem. 12 (1996) 185; Chem. Abstr. 126, 1442174, (1997).
32. Genin MJ, Biles C, Keiser BJ et al, J Med Chem, 43, 1034-40, (2000b).
33. G. V. Subbraju, A. Ranga Nayakulu, D. Parameshwara, Indian J. Heterocycl. Chem. 4 87, (1994).
34. Krishna R B, Panade R, Bhaithwal S P and Parmar S S, Eur Med J Chem., 15567, (1980).
35. Wagner E., Becan L. and Nowakowska E.; Bio. Org. Med. Chem.; 12, 265, (2004).
36. Troeberg, L.; Chen, X.; Flaherty, T. M.; Morty, R. E.; Cheng, M.; Hua, H.; Springer, C.; Mc Kerrow, J. H.; Kenyon, G. L.; Lonsdale-Eccles, J. D.; Coetzer, T. H. T.; Cohen, F. E. Chalcone, Mol. Med. (N.Y.) 6, 660-669, (2000), [Chem. Abstr. 2001, 134, 246896x].
37. B. Roman, Pharmazie 45, 214, (1990).
38. Azarifar, D.; Shaebanzadeh, M.; Molecules 7, 885-895, (2002).
39. Shekarchia M, Pirali-Hamedania B L, Navidpourb N, Adiba and Shafieeb A, J Iranian Chem Soc., 5, 150-158, (2008).
40. Francesc Puig-Basagoiti; Mark Tilgner, Brett M. Forshey, Seen M. Philpott, Noel G. Espina, Devid E. Wentworth, Scott J. Goebel, Paul S. Masters, Barry Falgout, Ping Ren, David M. Ferguson, and Pei-Yong Shi; vol. 50, No. 4, p. 1320-1329, April-(2006).
41. Yale, H. L.; Losee, K.; Martins, J.; Holsing, M.; Perry, F. M.; Bernstein, J. Chemotherapy of Experimental Tuberculosis. VIII. J. Am. Chem. Soc. 1953, 75, 1933-1942. Molecules, 8 754, (2003).
42. Corbett, E.L., Watt, C.J., Walker, N., Maher, D., Williams, B.G. Raviglione, M.C., and Dye, C, Arch Intern Med 163, 1009-1021, (2003).
43. M.A. Ali, M. Shaharyar, A. A. Siddiqui, Eur. J. Med. Chem. 42, 268-275, (2007).
44. M. Shaharyar, A.A. Siddiqui, M.A. Ali, D. Shriram, P. Yogeeshwari, Bioorg. Med. Chem. Lett.16, 3947-3949, (2006).
45. J. N. Domínguez, C. León, J. Rodrigues, N. Gamboa de Domínguez, J. Gut, J. Philip, P. J. Rosenthal, Farmaco, 60, 307-10, (2005).
46. Zhang, X.H.; Wu, S.K.; Gao, Z.Q.; Lee, C.S.; Lee, S.T.; Kwong, H.L. Thin Solid Films. 371, 40-46, (2000).
47. Suwalsky M, Orellana P, Avello M, Villena F. Food and Chemical Toxicology. 45, 130-135, (2007).
48. Tice CM, Bryman LM, Roemmele RC. Eur Pat Appl. 1994;EP 733622 [Chem Abstr. 125, 275903s, (1996).
49. Verma B L and Singhal M, Indian J Heterocycl Chem., 14, 343-346, (2007).
50. Desai NC, Nayan Bhatt, Mukesh Kumar. Indian J. Heterocyclic Chem. 17, 277-278, (2008).
51. M. A. El-Hashasn, F. M. A. Sulaiman, L. M. Souka, A. S. Salman, Rev. Roum. Chim. 40, 59, (1995).
52. G. Turan-Zitouni, P. Chevallet, F.S. Kiliç, K. Erol, Eur. J. Med. Chem. 35, 635e641, (2000).
53. M. S. Karthikeyan, B. S. Holla, N. S. Kumari, Eur. J. Med. Chem. 42, 30, (2007).
54. Habib NS, Soliman R, Ismail K, Hassan AM, Sarg MT, Pyrimidines. Part II: Boll Chim Farm, 142, 396-405, (2003).
55. Greenlee, R.-T.; Hill-Marmon, M.-B.; Murray, T.; Thun, M., Cancer J. Clin. 51, 15-36, (2001).